B-cell Lymphomas May Underlie HLH Development in Rare Cases, Report ShowsAlthough rare, B-cell lymphomas may be the underlying cause of hemophagocytic lymphohistiocytosis (HLH), and complete remission may be achieved with chemotherapy regimens containing etoposide and steroids, a case ... Read more
Nivolumab Effective Against Epstein-Barr Virus-Associated HLH, Analysis SuggestsThe cancer medication nivolumab (marketed as Opdivo) can successfully treat patients with secondary hemophagocytic lymphohistiocytosis (HLH) triggered by Epstein-Barr virus (EBV) infection, a study shows. In ... Read more
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.